Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino [4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insultsEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92024-04-016OAAI
Multi-Gram Scale Synthesis and Characterization of Mometasone Furoate EP Impurity CMOLECULESIF4.62023-11-300OAAI
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection新型含胍基异哌啶酰胺凝血因子抑制剂对SARS CoV-2病毒感染的评价VIRUSES-BASELIF3.52022-08-055OAAI
Assessing the Role of a Malonamide Linker in the Design of Potent Dual Inhibitors of Factor Xa and CholinesterasesMOLECULESIF4.62022-07-028OAAI
How a β-D-Glucoside Side Chain Enhances Binding Affinity to Thrombin of Inhibitors Bearing 2-Chlorothiophene as P1 Moiety: Crystallography, Fragment Deconstruction Study, and Evaluation of Antithrombotic PropertiesJOURNAL OF MEDICINAL CHEMISTRYIF6.82014-10-1413PREAI
Synthesis and Biological Evaluation of Direct Thrombin Inhibitors Bearing 4-(Piperidin-1-yl)pyridine at the P1 Position with Potent Anticoagulant ActivityJOURNAL OF MEDICINAL CHEMISTRYIF6.82013-10-2231PREAI
β-D-Glucosyl Conjugates of Highly Potent Inhibitors of Blood Coagulation Factor Xa Bearing 2-Chorothiophene as a P1 MotifCHEMMEDCHEMIF3.42012-07-318PREAI
Biarylmethoxy isonipecotanilides as potent and selective inhibitors of blood coagulation factor XaEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72011-02-0118PREAI
Novel factor Xa inhibitors: a patent reviewEXPERT OPINION ON THERAPEUTIC PATENTSIF4.62009-09-1040PREAI